FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claes-Göran AH Löfdahl

Research Profile

Disorders

Phenomena

Forced Expiratory Volume

Activities & Behaviors

Smoking

Chemicals & Drugs

Procedures

Geographic Areas

Sweden

Living Beings

Guinea Pigs

Anatomy

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Sophia Frantz; Claes-Göran AH Löfdahl; Ulf Nihlén; Magnus Dencker; Gunnar Engström; Per Wollmer
Atherosclerotic plaques in the internal carotid artery and associations with lung function assessed by different methods.
Kjell Larsson; Anders Lindén; Claes-Göran AH Löfdahl; Thomas Sandström; Gunnar S Johansson
[How the care of COPD will be better].
M Inghammar; Claes-Göran AH Löfdahl; N Winqvist; B Ljungberg; A Egesten; G Engström
Impaired pulmonary function and the risk of tuberculosis: a population-based cohort study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claes-Göran AH Löfdahl (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sophia Frantz; Claes-Göran AH Löfdahl; Ulf Nihlén; Magnus Dencker; Gunnar Engström; Per Wollmer
Atherosclerotic plaques in the internal carotid artery and associations with lung function assessed by different methods.
Clinical physiology and functional imaging 2012;32(2):120-5.
2011: Kjell Larsson; Anders Lindén; Claes-Göran AH Löfdahl; Thomas Sandström; Gunnar S Johansson
[How the care of COPD will be better].
Läkartidningen 2011;108(35):1604-5.
2011: M Inghammar; Claes-Göran AH Löfdahl; N Winqvist; B Ljungberg; A Egesten; G Engström
Impaired pulmonary function and the risk of tuberculosis: a population-based cohort study.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2011;37(5):1285-7.
2011: Cecilia K Andersson; Annika Andersson-Sjöland; Leif Bjermer; Leif Eriksson; Oskar Hallgren; Claes-Göran AH Löfdahl; Michiko Mori; Annie Pardo; Moises Selman; Gunilla Westergren-Thorsson; Jonas S Erjefält
Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.
Respiratory research 2011;12():139.
2010: Claes-Göran AH Löfdahl; Björn Tilling; Tommy Ekström; Leif Jörgensen; Gunnar Johansson; Kjell Larsson
COPD health care in Sweden - A study in primary and secondary care.
Respiratory medicine 2010;104(3):404-11.
2010: Cecilia K Andersson; Michiko Mori; Leif Bjermer; Claes-Göran AH Löfdahl; Jonas S Erjefält
Alterations in lung mast cell populations in patients with chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine 2010;181(3):206-17.
2010: Oskar Hallgren; Kristian Nihlberg; Magnus Dahlbäck; Leif Bjermer; Leif Eriksson; Jonas S Erjefält; Claes-Göran AH Löfdahl; Gunilla Westergren-Thorsson
Altered fibroblast proteoglycan production in COPD.
Respiratory research 2010;11():55.
2010: Malin Inghammar; Anders Ekbom; Gunnar Engström; Bengt Ljungberg; Victoria Romanus; Claes-Göran AH Löfdahl; Arne Egesten
COPD and the risk of tuberculosis--a population-based cohort study.
PloS one 2010;5(4):e10138.
2009: Caroline Düringer; Gunilla Grundström; Eylem Gürcan; Ian A Dainty; Mandy Lawson; Solange H Korn; Anders Jerre; Hanna Falk Håkansson; Elisabet Wieslander; Karin Fredriksson; Carl Magnus Sköld; Magnus Löfdahl; Claes-Göran AH Löfdahl; David J Nicholls; David S Silberstein
Agonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposure.
British journal of pharmacology 2009;158(1):169-79.
2009: C K Andersson; M Mori; Leif Bjermer; Claes-Göran AH Löfdahl; Jonas S Erjefält
Novel site-specific mast cell subpopulations in the human lung.
Thorax 2009;64(4):297-305.
2009: Gunnar Engström; N Segelstorm; M Ekberg-Aronsson; Peter M Nilsson; Folke Lindgärde; Claes-Göran AH Löfdahl
Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study.
Thorax 2009;64(3):211-5.
2008: Claes-Göran AH Löfdahl
COPD and co-morbidities, with special emphasis on cardiovascular conditions.
The clinical respiratory journal 2008;2 Suppl 1():59-63.
2008: Björn Ställberg; T Ekström; F Neij; P Olsson; Bengt-Eric Skoogh; G Wennergren; Claes-Göran AH Löfdahl
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma.
Respiratory medicine 2008;102(10):1360-70.
2008: Ulf Nihlén; Peter Montnémery; Morgan Andersson; Carl G A Persson; Per Nyberg; Claes-Göran AH Löfdahl; Lennart Greiff
Specific nasal symptoms and symptom-provoking factors may predict increased risk of developing COPD.
Clinical physiology and functional imaging 2008;28(4):240-50.
2008: Arne Egesten; Lena Brandt; Tomas Olsson; Fredrik Granath; Malin Inghammar; Claes-Göran AH Löfdahl; Anders Ekbom
Increased prevalence of multiple sclerosis among COPD patients and their first-degree relatives: a population-based study.
Lung 2008;186(3):173-8.
2008: Anders Ekbom; Lena Brandt; Fredrik Granath; Claes-Göran AH Löfdahl; Arne Egesten
Increased risk of both ulcerative colitis and Crohn's disease in a population suffering from COPD.
Lung 2008;186(3):167-72.
2008: Marie Ekberg-Aronsson; Kerstin Löfdahl; Jan-Ake Nilsson; Claes-Göran AH Löfdahl; Peter M Nilsson
Hospital admission rates among men and women with symptoms of chronic bronchitis and airflow limitation corresponding to the GOLD stages of chronic obstructive pulmonary disease--a population-based study.
Respiratory medicine 2008;102(1):109-20.
2007: Sven A Larsson; Claes-Göran AH Löfdahl
[The COPD national guidelines do have a future].
Läkartidningen 2007;104(24-25):1891.
2007: Brian J O'connor; Claes-Göran AH Löfdahl; Meyer Balter; Andrew Szczeklik; Louis-Philippe Boulet; Charles Cairns
Zileuton added to low-dose inhaled beclomethasone for the treatment of moderate to severe persistent asthma.
Respiratory medicine 2007;101(6):1088-96.
2007: Claes-Göran AH Löfdahl; Dirkje S Postma; N B Pride; J Boe; A Thorén
Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2007;29(6):1115-9.
2007: Amelie Plymoth; Claes-Göran AH Löfdahl; Ann Ekberg-Jansson; Magnus Dahlbäck; Per Broberg; martyn foster; Thomas E Fehniger; György Marko-Varga
Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers.
Clinical chemistry 2007;53(4):636-44.
2007: Sven A Larsson; Claes-Göran AH Löfdahl
[COPD--a multifactorial systemic disease].
Läkartidningen 2007;104(13):1028-31.
2007: Marie Ekberg-Aronsson; Peter M Nilsson; Jan-Ake Nilsson; Claes-Göran AH Löfdahl; K Löfdahl
Mortality risks among heavy-smokers with special reference to women: a long-term follow-up of an urban population.
European journal of epidemiology 2007;22(5):301-9.
2006: Ulf Nihlén; Lennart Greiff; Peter Montnémery; Claes-Göran AH Löfdahl; A Johannisson; C Persson; Morgan Andersson
Incidence and remission of self-reported allergic rhinitis symptoms in adults.
Allergy 2006;61(11):1299-304.
2006: L Watson; Jan Schouten; Claes-Göran AH Löfdahl; NB Pride; LA Laitinen; Dirkje S Postma
Predictors of COPD symptoms: does the sex of the patient matter?
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2006;28(2):311-8.
2006: Romain Kessler; Elisabeth Ståhl; Claus Vogelmeier; John Haughney; Elyse Trudeau; Claes-Göran AH Löfdahl; Martyn R Partridge
Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study.
Chest 2006;130(1):133-42.
2006: Pernilla Glader; Karin von Wachenfeldt; Claes-Göran AH Löfdahl
Systemic CD4+ T-cell activation is correlated with FEV1 in smokers.
Respiratory medicine 2006;100(6):1088-93.
2006: R Montnémery; Ulf Nihlén; M Andersson; L Greiff; A Johannisson; P Nyberg; Carl G A Persson; Claes-Göran AH Löfdahl
Obstructive airways diseases, smoking and use of inhaled corticosteroids in southern Sweden in 1992 and 2000.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2006;10(5):490-8.
2006: Pernilla Glader; Sebastian Möller; Johanna Lilja; Elisabet Wieslander; Claes-Göran AH Löfdahl; Karin von Wachenfeldt
Cigarette smoke extract modulates respiratory defence mechanisms through effects on T-cells and airway epithelial cells.
Respiratory medicine 2006;100(5):818-27.
2006: Amelie Plymoth; Ziping Yang; Claes-Göran AH Löfdahl; Ann Ekberg-Jansson; Magnus Dahlbäck; Thomas E Fehniger; György Marko-Varga; William S Hancock
Rapid proteome analysis of bronchoalveolar lavage samples of lifelong smokers and never-smokers by micro-scale liquid chromatography and mass spectrometry.
Clinical chemistry 2006;52(4):671-9.
2006: L Watson; Judith M Vonk; Claes-Göran AH Löfdahl; NB Pride; Romain A Pauwels; LA Laitinen; Jan Schouten; Dirkje S Postma
Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
Respiratory medicine 2006;100(4):746-53.
2006: Marie Ekberg-Aronsson; Peter M Nilsson; Jan-Ake Nilsson; Kerstin Pehrsson; Claes-Göran AH Löfdahl
Socio-economic status and lung cancer risk including histologic subtyping--a longitudinal study.
Lung cancer (Amsterdam, Netherlands) 2006;51(1):21-9.
2005: Gunnar Hillerdal; Claes-Göran AH Löfdahl; Kerstin Ström; Bengt-Eric Skoogh; Lennart Jorfeldt; Folke Nilsson; Dycke Forslund-Stiby; Jonas Ranstam; Erik Gyllstedt
Comparison of lung volume reduction surgery and physical training on health status and physiologic outcomes: a randomized controlled clinical trial.
Chest 2005;128(5):3489-99.
2005: John Haughney; M R Partridge; Claus Vogelmeier; T Larsson; Romain Kessler; Elisabeth Ståhl; R Brice; Claes-Göran AH Löfdahl
Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2005;26(4):623-9.
2005: P Calverley; R Pauwels Dagger; Claes-Göran AH Löfdahl; Klas Svensson; T Higenbottam; LG Carlsson; Elisabeth Ståhl
Relationship between respiratory symptoms and medical treatment in exacerbations of COPD.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2005;26(3):406-13.
2005: György Marko-Varga; Henrik Lindberg; Claes-Göran AH Löfdahl; Per Jönsson; Lennart Hansson; Magnus Dahlbäck; Eva Lindquist; Leif Johansson; martyn foster; Thomas E Fehniger
Discovery of biomarker candidates within disease by protein profiling: principles and concepts.
Journal of proteome research 2005;4(4):1200-12.
2005: Marc Decramer; Rik Gosselink; P Bartsch; Claes-Göran AH Löfdahl; W Vincken; R Dekhuijzen; J Vestbo; R Pauwels; R Naeije; Thierry Troosters
Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004.
Thorax 2005;60(4):343-9.
2005: Pernilla Glader; Claes-Göran AH Löfdahl; Karin von Wachenfeldt
alphaEbeta7 expression on CD8+ T-cells in COPD BAL fluid and on TGF-beta stimulated T-cells in vitro.
Lung 2005;183(2):123-38.
2005: Peter Montnémery; Ulf Nihlén; Claes-Göran AH Löfdahl; Per Nyberg; Ake Svensson
Prevalence of hand eczema in an adult Swedish population and the relationship to risk occupation and smoking.
Acta dermato-venereologica 2005;85(5):429-32.
2005: Elisabeth Ståhl; Anne Lindberg; Sven-Arne Jansson; Eva Rönmark; Klas Svensson; Fredrik L Andersson; Claes-Göran AH Löfdahl; Bo Lundbäck
Health-related quality of life is related to COPD disease severity.
Health and quality of life outcomes 2005;3():56.
2005: Marie Ekberg-Aronsson; Kerstin Pehrsson; Jan-Ake Nilsson; Peter M Nilsson; Claes-Göran AH Löfdahl
Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis.
Respiratory research 2005;6():98.
2005: Claes-Göran AH Löfdahl; Asa Ericsson; Klas Svensson; Emma Andreasson
Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used alone.
PharmacoEconomics 2005;23(4):365-75.
2005: Ann Ekberg-Jansson; Kawa Amin; Björn Bake; Annika Rosengren; Ulf Tylen; Per Venge; Claes-Göran AH Löfdahl
Bronchial mucosal mast cells in asymptomatic smokers relation to structure, lung function and emphysema.
Respiratory medicine 2005;99(1):75-83.
2004: Kristoffer Larsen; Ellen Tufvesson; Johan Malmström; Matthias Mörgelin; Marie Wildt; Annika Andersson; Anna Lindström; Anders Malmström; Claes-Göran AH Löfdahl; György Marko-Varga; Leif Bjermer; Gunilla Westergren-Thorsson
Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma.
American journal of respiratory and critical care medicine 2004;170(10):1049-56.
2004: Terese Dajotoy; Pia Andersson; Anders Bjartell; Claes-Göran AH Löfdahl; Hans Tapper; Arne Egesten
Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma.
Journal of leukocyte biology 2004;76(3):685-91.
2004: Ulf Nihlén; Per Nyberg; Peter Montnémery; Claes-Göran AH Löfdahl
Influence of family history and smoking habits on the incidence of self-reported physician's diagnosis of COPD.
Respiratory medicine 2004;98(3):263-70.
2004: Romain Pauwels; P M A Calverley; A Sonia Buist; S Rennard; Y Fukuchi; E Stahl; Claes-Göran AH Löfdahl
COPD exacerbations: the importance of a standard definition.
Respiratory medicine 2004;98(2):99-107.
2003: Elisabeth Ståhl; Dirkje S Postma; Klas Svensson; Anne E Tattersfield; Arne Eivindson; Ad Schreurs; Claes-Göran AH Löfdahl
Formoterol used as needed improves health-related quality of life in asthmatic patients uncontrolled with inhaled corticosteroids.
Respiratory medicine 2003;97(9):1061-6.
2003: Peter Montnémery; M Popovic; Morgan Andersson; Lennart Greiff; Per Nyberg; Claes-Göran AH Löfdahl; C Svensson; Carl G A Persson
Influence of heavy traffic, city dwelling and socio-economic status on nasal symptoms assessed in a postal population survey.
Respiratory medicine 2003;97(8):970-7.
2003: Amelie Plymoth; Claes-Göran AH Löfdahl; Ann Ekberg-Jansson; Magnus Dahlbäck; Henrik Lindberg; Thomas E Fehniger; György Marko-Varga
Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation.
Proteomics 2003;3(6):962-72.
2003: Ulf Nihlén; Morgan Andersson; Claes-Göran AH Löfdahl; Carl G A Persson; Peter Montnémery; Lennart Greiff
Nasal neutrophil activity and mucinous secretory responsiveness in COPD.
Clinical physiology and functional imaging 2003;23(3):138-42.
2003: Anders Lindén; L Hansson; A Andersson; Mona Palmqvist; Pernilla Arvidsson; Claes-Göran AH Löfdahl; Per Larsson; Jan Lötvall
Bronchodilation by an inhaled VPAC(2) receptor agonist in patients with stable asthma.
Thorax 2003;58(3):217-21.
2003: Kawa Amin; Ann Ekberg-Jansson; Claes-Göran AH Löfdahl; Per Venge
Relationship between inflammatory cells and structural changes in the lungs of asymptomatic and never smokers: a biopsy study.
Thorax 2003;58(2):135-42.
2003: Elisabeth Ståhl; D S Postma; E F Juniper; Klas Svensson; I Mear; Claes-Göran AH Löfdahl
Health-related quality of life in asthma studies. Can we combine data from different countries?
Pulmonary pharmacology & therapeutics 2003;16(1):53-9.
2003: Johan Malmström; Ellen Tufvesson; Claes-Göran AH Löfdahl; Lennart Hansson; György Marko-Varga; Gunilla Westergren-Thorsson
Activation of platelet-derived growth factor pathway in human asthmatic pulmonary-derived mesenchymal cells.
Electrophoresis 2003;24(1-2):276-85.
2002: M Wadbo; Claes-Göran AH Löfdahl; K Larsson; Bengt-Eric Skoogh; Göran Tornling; E Arweström; T Bengtsson; Kerstin Ström
Effects of formoterol and ipratropium bromide in COPD: a 3-month placebo-controlled study.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2002;20(5):1138-46.
2002: Susanne Larsson; Lennart Hansson; Lennart Greiff; Claes-Göran AH Löfdahl; Carl G A Persson; Per Broberg; Margareta Linden
Natural allergen exposure does not diminish the sensitivity of cytokine production to glucocorticosteroids in blood cells of seasonal allergic asthma and rhinitis patients.
Respiratory medicine 2002;96(11):927-33.
2002: Louise Lannefors; Ola Persson; Claes-Göran AH Löfdahl
[Better routines in connection with nebulizer therapy are required. New European guidelines serve as a guidance in Swedish health care, too].
Läkartidningen 2002;99(42):4176-80.
2002: Peter Montnémery; L Hansson; Jan Lanke; L-H Lindholm; P Nyberg; Claes-Göran AH Löfdahl; Ellinor Adelroth
Accuracy of a first diagnosis of asthma in primary health care.
Family practice 2002;19(4):365-8.
2002: O Johnell; R Pauwels; Claes-Göran AH Löfdahl; LA Laitinen; Dirkje S Postma; NB Pride; SV Ohlsson
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2002;19(6):1058-63.
2002: Johan Malmström; Kristoffer Larsen; Lennart Hansson; Claes-Göran AH Löfdahl; Ole Nörregard-Jensen; György Marko-Varga; Gunilla Westergren-Thorsson
Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation: a feasibility study.
Proteomics 2002;2(4):394-404.
2001: Lars Thorsson; S Edsbäcker; Anders Källén; Claes-Göran AH Löfdahl
Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler.
British journal of clinical pharmacology 2001;52(5):529-38.
2001: Peter Montnémery; P Bengtsson; A Elliot; LH Lindholm; Per Nyberg; Claes-Göran AH Löfdahl
Prevalence of obstructive lung diseases and respiratory symptoms in relation to living environment and socio-economic group.
Respiratory medicine 2001;95(9):744-52.
2001: Fredrik L Andersson; E Stahl; Peter J Barnes; Claes-Göran AH Löfdahl; Paul M O'Byrne; Romain A Pauwels; Dirkje S Postma; Anne E Tattersfield; Anders Ullman
Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study.
Respiratory medicine 2001;95(6):505-12.
2001: Ann Ekberg-Jansson; Susanne Larsson; Claes-Göran AH Löfdahl
Preventing exacerbations of chronic bronchitis and COPD.
BMJ (Clinical research ed.) 2001;322(7297):1259-61.
2001: Ann Ekberg-Jansson; B Andersson; Björn Bake; M Boijsen; I Enanden; Annika Rosengren; Bengt-Eric Skoogh; Ulf Tylen; Per Venge; Claes-Göran AH Löfdahl
Neutrophil-associated activation markers in healthy smokers relates to a fall in DL(CO) and to emphysematous changes on high resolution CT.
Respiratory medicine 2001;95(5):363-73.
2001: Pernilla Arvidsson; Claes-Göran AH Löfdahl; Bengt-Eric Skoogh; Jan Lötvall
Exudation of plasma and production of thromboxane in human bronchi after local bradykinin challenge.
Respiratory medicine 2001;95(5):313-8.
2001: Peter Montnémery; C Svensson; Ellinor Adelroth; Claes-Göran AH Löfdahl; Morgan Andersson; Lennart Greiff; Carl G A Persson
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2001;17(4):596-603.
2001: Anne E Tattersfield; Claes-Göran AH Löfdahl; D S Postma; A Eivindson; A G Schreurs; A Rasidakis; T Ekström
Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.
Lancet 2001;357(9252):257-61.
2001: Ulf Nihlén; Peter Montnémery; L H Lindholm; Claes-Göran AH Löfdahl
Increased serum levels of carbohydrate-deficient transferrin in patients with chronic obstructive pulmonary disease.
Scandinavian journal of clinical and laboratory investigation 2001;61(5):341-7.
2001: Ann Ekberg-Jansson; Björn Bake; B Andersson; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl
Respiratory symptoms relate to physiological changes and inflammatory markers reflecting central but not peripheral airways. A study in 60-year-old 'healthy' smokers and never-smokers.
Respiratory medicine 2001;95(1):40-7.
2000: Ann Ekberg-Jansson; B Andersson; E Avrå; O Nilsson; Claes-Göran AH Löfdahl
The expression of lymphocyte surface antigens in bronchial biopsies, bronchoalveolar lavage cells and blood cells in healthy smoking and never-smoking men, 60 years old.
Respiratory medicine 2000;94(3):264-72.
2000: L Jacobson; P Hertzman; Claes-Göran AH Löfdahl; Bengt-Eric Skoogh; B Lindgren
The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991.
Respiratory medicine 2000;94(3):247-55.
2000: Peter Montnémery; Jan Lanke; LH Lindholm; B Lundbäck; Per Nyberg; Ellinor Adelroth; Claes-Göran AH Löfdahl
Familial related risk-factors in the development of chronic bronchitis/emphysema as compared to asthma assessed in a postal survey.
European journal of epidemiology 2000;16(11):1003-7.
2000: Ulf Tylen; M Boijsen; Ann Ekberg-Jansson; Björn Bake; Claes-Göran AH Löfdahl
Emphysematous lesions and lung function in healthy smokers 60 years of age.
Respiratory medicine 2000;94(1):38-43.
1999: Ulf Nihlén; Peter Montnémery; LH Lindholm; Claes-Göran AH Löfdahl
Detection of chronic obstructive pulmonary disease (COPD) in primary health care: role of spirometry and respiratory symptoms.
Scandinavian journal of primary health care 1999;17(4):232-7.
1999: Elizabeth F Juniper; Klas Svensson; Paul M O'Byrne; Peter J Barnes; C A Bauer; Claes-Göran AH Löfdahl; Dirkje S Postma; Romain A Pauwels; Anne E Tattersfield; Anders Ullman
Asthma quality of life during 1 year of treatment with budesonide with or without formoterol.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1999;14(5):1038-43.
1999: Ann Ekberg-Jansson; E Arvå; O Nilsson; Claes-Göran AH Löfdahl; B Andersson
A comparison of the expression of lymphocyte activation markers in blood, bronchial biopsies and bronchoalveolar lavage: evidence for an enrichment of activated T lymphocytes in the bronchoalveolar space.
Respiratory medicine 1999;93(8):563-70.
1999: Anne E Tattersfield; Dirkje S Postma; Peter J Barnes; Klas Svensson; C A Bauer; Paul M O'Byrne; Claes-Göran AH Löfdahl; Romain A Pauwels; Anders Ullman
Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.
American journal of respiratory and critical care medicine 1999;160(2):594-9.
1999: Claes-Göran AH Löfdahl; Theodore F Reiss; Jonathan A Leff; E Israel; Michael Noonan; A F Finn; BC Seidenberg; T Capizzi; S Kundu; P Godard
Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients.
BMJ (Clinical research ed.) 1999;319(7202):87-90.
1999: Romain A Pauwels; Claes-Göran AH Löfdahl; LA Laitinen; Jan Schouten; Dirkje S Postma; NB Pride; SV Ohlsson
Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.
The New England journal of medicine 1999;340(25):1948-53.
1999: Susanne Larsson; Claes-Göran AH Löfdahl; Margareta Linden
IL-2 and IL-4 counteract budesonide inhibition of GM-CSF and IL-10, but not of IL-8, IL-12 or TNF-alpha production by human mononuclear blood cells.
British journal of pharmacology 1999;127(4):980-6.
1999: Anders Lindén; A Bergendal; Jan Lötvall; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl
Effect of nedocromil sodium on non-adrenergic, non-cholinergic neural responses in guinea pig bronchi in vitro.
Regulatory peptides 1999;81(1-3):49-53.
1998: Peter Montnémery; Ellinor Adelroth; K Heuman; A Johannisson; S A Johansson; LH Lindholm; B Lundbäck; Claes-Göran AH Löfdahl
Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden.
Respiratory medicine 1998;92(12):1337-45.
1998: Claes-Göran AH Löfdahl
[Corticosteroids].
Revue des maladies respiratoires 1998;15 Suppl 2():S42-4.
1998: LG Carlsson; E Arweström; K Friberg; Anders Källén; H Lunde; Claes-Göran AH Löfdahl
Efficacy of cumulative doses of salbutamol administered via Turbuhaler or Diskhaler in patients with reversible airway obstruction.
Allergy 1998;53(7):712-5.
1998: Claes-Göran AH Löfdahl; Dirkje S Postma; LA Laitinen; SV Ohlsson; Romain A Pauwels; NB Pride
The European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): recruitment methods and strategies.
Respiratory medicine 1998;92(3):467-72.
1998: Eva Bondesson; K Friberg; S Soliman; Claes-Göran AH Löfdahl
Safety and efficacy of a high cumulative dose of salbutamol inhaled via Turbuhaler or via a pressurized metered-dose inhaler in patients with asthma.
Respiratory medicine 1998;92(2):325-30.
1998: Apichart Nana; P Youngchaiyud; Nanta Maranetra; J Boe; Claes-Göran AH Löfdahl; O Selroos; Elisabeth Ståhl
Beta 2-agonists administered by a dry powder inhaler can be used in acute asthma.
Respiratory medicine 1998;92(2):167-72.
1998: Apichart Nana; P Youngchaiyud; Suchai Charoenratanakul; J Boe; Claes-Göran AH Löfdahl; O Selroos; Elisabeth Ståhl
High-dose inhaled budesonide may substitute for oral therapy after an acute asthma attack.
The Journal of asthma : official journal of the Association for the Care of Asthma 1998;35(8):647-55.
1997: Romain A Pauwels; Claes-Göran AH Löfdahl; Dirkje S Postma; Anne E Tattersfield; Paul M O'Byrne; Peter J Barnes; Anders Ullman
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
The New England journal of medicine 1997;337(20):1405-11.
1997: Claes-Göran AH Löfdahl; L Andersson; Eva Bondesson; LG Carlsson; K Friberg; Jan Hedner; Y Hörnblad; P Jemsby; Anders Källén; Anders Ullman; S Werner; N Svedmyr
Differences in bronchodilating potency of salbutamol in Turbuhaler as compared with a pressurized metered-dose inhaler formulation in patients with reversible airway obstruction.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1997;10(11):2474-8.
1996: Gunnar Hillerdal; Claes-Göran AH Löfdahl; L Orre; B E Skoogh; E Gyllstedt; K Ström; F Nilsson; O Nettelbladt; P A Kling
[Reduced lung volume means better respiration. A new surgical technique for emphysema in a Swedish study].
Läkartidningen 1996;93(44):3910, 3915-6.
1996: A Ullman; Claes-Göran AH Löfdahl; B Melander; N Svedmyr
Formoterol inhaled as dry powder or via pressurized metered-dose inhaler in a cumulative dose-response study.
Allergy 1996;51(10):745-8.
1996: I Kawikova; H Arakawa; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl; Jan Lötvall
U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF.
The Journal of pharmacology and experimental therapeutics 1996;278(1):268-76.
1996: A Bergendal; Anders Lindén; Bengt-Eric Skoogh; Marc Gerspacher; Gary P Anderson; Claes-Göran AH Löfdahl
Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues.
British journal of pharmacology 1996;117(6):1009-15.
1996: Anders Lindén; K F Rabe; Claes-Göran AH Löfdahl
Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
Lung 1996;174(1):1-22.
1996: N Svedmyr; Claes-Göran AH Löfdahl
The use of beta 2-adrenoceptor agonists in the treatment of bronchial asthma.
Pharmacology & toxicology 1996;78(1):3-11.
1995: A Bergendal; A Johansson; B Bake; Jan Lötvall; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl
Airway effects of salmeterol in healthy individuals.
Pulmonary pharmacology 1995;8(6):283-8.
1995: H Arakawa; Jan Lötvall; I Kawikova; A Morikawa; Claes-Göran AH Löfdahl; Bengt-Eric Skoogh
Airway responses following intradermal sensitization to different types of allergens: ovalbumin, trimellitic anhydride and Dermatophagoides farinae.
International archives of allergy and immunology 1995;108(3):274-80.
1995: I Kawikova; H Arakawa; M Petersson; Claes-Göran AH Löfdahl; Bengt-Eric Skoogh; Jan Lötvall
Bradykinin-induced release of thromboxane B2 into bronchoalveolar lavage fluid of guinea pigs: relationship to airflow obstruction.
European journal of pharmacology 1995;280(3):293-9.
1995: A Bergendal; Anders Lindén; Jan Lötvall; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl
Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.
British journal of pharmacology 1995;114(7):1478-82.
1994: Gerdt C Riise; Susanne Larsson; Claes-Göran AH Löfdahl; Bengt A Andersson
Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1994;7(9):1673-7.
1994: H Arakawa; Jan Lötvall; I Kawikova; K Tokuyama; Claes-Göran AH Löfdahl; Bengt-Eric Skoogh
Effect of maturation on airway plasma exudation induced by eicosanoids in guinea pig.
European journal of pharmacology 1994;259(3):251-7.
1994: H Arakawa; Jan Lötvall; Anders Lindén; I Kawikova; Claes-Göran AH Löfdahl; Bengt-Eric Skoogh
Role of eicosanoids in airflow obstruction and airway plasma exudation induced by trimellitic anhydride-conjugate in guinea-pigs 3 and 8 weeks after sensitization.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1994;24(6):582-9.
1994: H Arakawa; P Andius; I Kawikova; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl; Jan Lötvall
Treatment with cyclosporin A during sensitization with trimellitic anhydride attenuates the airway responses to allergen challenge three weeks later.
European journal of pharmacology 1994;252(3):313-9.
1993: I Kawikova; H Arakawa; Claes-Göran AH Löfdahl; Bengt-Eric Skoogh; Jan Lötvall
Bradykinin-induced airflow obstruction and airway plasma exudation: effects of drugs that inhibit acetylcholine, thromboxane A2 or leukotrienes.
British journal of pharmacology 1993;110(2):657-64.
1993: H Arakawa; Jan Lötvall; I Kawikova; R Tee; J Hayes; Claes-Göran AH Löfdahl; A J Taylor; Bengt-Eric Skoogh
Airway allergy to trimellitic anhydride in guinea pigs: different time courses of IgG1 titer and airway responses to allergen challenge.
The Journal of allergy and clinical immunology 1993;92(3):425-34.
1993: H Arakawa; Jan Lötvall; I Kawikova; Claes-Göran AH Löfdahl; Bengt-Eric Skoogh
Leukotriene D4- and prostaglandin F2 alpha-induced airflow obstruction and airway plasma exudation in guinea-pig: role of thromboxane and its receptor.
British journal of pharmacology 1993;110(1):127-32.
1993: Anders Lindén; A Ullman; Claes-Göran AH Löfdahl; Bengt-Eric Skoogh
Non-adrenergic, non-cholinergic neural activation in guinea-pig bronchi: powerful and frequency-dependent stabilizing effect on tone.
British journal of pharmacology 1993;109(3):845-51.
1993: H Arakawa; I Kawikova; Bengt-Eric Skoogh; J Hayes; A Morikawa; Claes-Göran AH Löfdahl; Jan Lötvall
Role of arachidonic acid metabolites in airway responses induced by trimellitic anhydride in actively sensitized guinea pigs.
The American review of respiratory disease 1993;147(5):1116-21.
1993: Anders Lindén; A Bergendal; A Ullman; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl
Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
Thorax 1993;48(5):547-53.
1993: Anders Lindén; Claes-Göran AH Löfdahl; A Ullman; Bengt-Eric Skoogh
Nonadrenergic, noncholinergic responses stabilize smooth muscle tone, with and without parasympathetic activation, in guinea-pig isolated airways.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1993;6(3):425-33.
1993: Anders Lindén; A Ullman; Claes-Göran AH Löfdahl; Bengt-Eric Skoogh
The NANC system as a stabilizer of airway smooth-muscle tone.
Pharmacology & toxicology 1993;72 Suppl 3():28-9.
1993: P Arvidsson; S Larsson; Claes-Göran AH Löfdahl
Objective and subjective bronchodilation over 12 hours after inhaled formoterol: individual responses.
The Journal of asthma : official journal of the Association for the Care of Asthma 1993;30(6):459-65.
1992: H Arakawa; I Kawikova; Claes-Göran AH Löfdahl; Jan Lötvall
Bradykinin-induced airway responses in guinea pig: effects of inhibition of cyclooxygenase and thromboxane synthetase.
European journal of pharmacology 1992;229(2-3):131-6.
1992: Romain A Pauwels; Claes-Göran AH Löfdahl; NB Pride; Dirkje S Postma; LA Laitinen; S V Ohlsson
European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1992;5(10):1254-61.
1992: Claes-Göran AH Löfdahl; N Svedmyr
[Adrenergic beta 2-agonists are to be considered more as friends than enemies].
Läkartidningen 1992;89(32-33):2572-3.
1992: A Ullman; A Bergendal; Anders Lindén; B Waldeck; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl
Onset of action and duration of effect of formoterol and salmeterol compared to salbutamol in isolated guinea pig trachea with or without epithelium.
Allergy 1992;47(4 Pt 2):384-7.
1992: Anders Lindén; A Ullman; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl
The non-adrenergic, non-cholinergic response counteracts changes in guinea-pig airway tone with and without sympathetic activation.
British journal of pharmacology 1992;106(3):616-22.
1992: A Bergendal; Anders Lindén; Jan Lötvall; A Ullman; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl
In vitro tachyphylaxis to isoprenaline in guinea-pig trachea: influence of theophylline?
Pharmacology & toxicology 1992;71(1):41-4.
1992: J Lötvall; K Rabe; K Tokuyama; Claes-Göran AH Löfdahl; Peter J Barnes; K Fan Chung
Neutrophil influx into guinea-pig airway lumen during cholinergic and non-cholinergic bronchoconstriction.
Acta physiologica Scandinavica 1992;144(1):101-6.
1991: P Arvidsson; S Larsson; Claes-Göran AH Löfdahl; B Melander; N Svedmyr; L Wåhlander
Inhaled formoterol during one year in asthma: a comparison with salbutamol.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1991;4(10):1168-73.
1991: Claes-Göran AH Löfdahl; N Svedmyr
Beta-agonists--friends or foes?
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1991;4(10):1161-5.
1991: Anders Lindén; A Ullman; Claes-Göran AH Löfdahl; Bengt-Eric Skoogh
Non-adrenergic, non-cholinergic neural activation stabilizes smooth-muscle tone independently of eicosanoid factors in guinea-pig isolated airways.
British journal of pharmacology 1991;104(2):509-13.
1991: Anders Lindén; Claes-Göran AH Löfdahl; A Ullman; Bengt-Eric Skoogh
In vitro characteristics of spontaneous airway tone in the guinea-pig.
Acta physiologica Scandinavica 1991;142(3):351-7.
1991: Jan Lötvall; K Tokuyama; Claes-Göran AH Löfdahl; A Ullman; Peter J Barnes; K Fan Chung
Peptidase modulation of noncholinergic vagal bronchoconstriction and airway microvascular leakage.
Journal of applied physiology (Bethesda, Md. : 1985) 1991;70(6):2730-5.
1991: A Ullman; G Ciabattoni; N Svedmyr; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl
Tetrodotoxin does not block the epithelium-dependent release of prostaglandin E2 induced by electrical field stimulation in isolated ferret trachea.
American journal of respiratory cell and molecular biology 1991;4(3):243-7.
1991: J O Lötvall; K P Hui; Claes-Göran AH Löfdahl; Peter J Barnes; K Fan Chung
Capsaicin pretreatment does not inhibit allergen-induced airway microvascular leakage in guinea pig.
Allergy 1991;46(2):105-8.
1991: Claes-Göran AH Löfdahl; K F Chung
Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1991;4(2):218-26.
1991: K Tokuyama; J O Lötvall; Claes-Göran AH Löfdahl; Peter J Barnes; K Fan Chung
Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakage.
European journal of pharmacology 1991;193(1):35-9.
1991: Anders Lindén; A Ullman; Bengt-Eric Skoogh; Claes-Göran AH Löfdahl
Non-adrenergic, non-cholinergic regulation of guinea-pig airway smooth muscle-indomethacin-induced changes and segmental differences.
Pulmonary pharmacology 1991;4(3):170-6.
1990: R Dahl; Claes-Göran AH Löfdahl
Precise diagnosis of airflow obstruction - does it matter for treatment? The assessment of reversibility; what drugs?
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1990;3(9):1087-8.
1990: A Ullman; Claes-Göran AH Löfdahl; N Svedmyr; Bengt-Eric Skoogh
Nerve stimulation releases mucosa-derived inhibitory factors, both prostanoids and nonprostanoids, in isolated ferret trachea.
The American review of respiratory disease 1990;141(3):748-51.
1990: Claes-Göran AH Löfdahl; S Larsson; B E Skoogh
Points of importance in long term intervention studies in CB/COAD.
Agents and actions. Supplements 1990;30():281-7.
1990: A Ullman; G Ciabattoni; Claes-Göran AH Löfdahl; Anders Lindén; N Svedmyr; Bengt-Eric Skoogh
Epithelium-derived PGE2 inhibits the contractile response to cholinergic stimulation in isolated ferret trachea.
Pulmonary pharmacology 1990;3(3):155-60.
1990: Claes-Göran AH Löfdahl
Basic pharmacology of new long-acting sympathomimetics.
Lung 1990;168 Suppl():18-21.
1989: Claes-Göran AH Löfdahl; N Svedmyr
Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration.
Allergy 1989;44(4):264-71.
1989: P Arvidsson; S Larsson; Claes-Göran AH Löfdahl; B Melander; L Wåhlander; N Svedmyr
Formoterol, a new long-acting bronchodilator for inhalation.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1989;2(4):325-30.
1989: A B Jeppsson; Claes-Göran AH Löfdahl; B Waldeck; E Widmark
On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration.
Pulmonary pharmacology 1989;2(2):81-5.
1989: Claes-Göran AH Löfdahl; A Sigvaldasson; Bengt-Eric Skoogh; N Svedmyr
Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment.
Respiration; international review of thoracic diseases 1989;55 Suppl 2():15-9.
1989: B E Skoogh; J Löthwall; Claes-Göran AH Löfdahl; N Svedmyr
Classification of beta-adrenoceptors in ferret tracheal smooth muscle by pharmacological responses.
Pulmonary pharmacology 1989;1(4):173-7.
1989: Claes-Göran AH Löfdahl
Antihypertensive drugs and airway function, with special reference to calcium channel blockade.
Journal of cardiovascular pharmacology 1989;14 Suppl 10():S40-51; discussion S59-62.
1988: A Ullman; Claes-Göran AH Löfdahl; N Svedmyr; L Bernsten; Bengt-Eric Skoogh
Mucosal inhibition of cholinergic contractions in ferret trachea can be transferred between organ baths.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1988;1(10):908-12.
1988: Claes-Göran AH Löfdahl; Carl G H Dahlöf; G Westergren; B Olofsson; N Svedmyr
Controlled-release metoprolol compared with atenolol in asthmatic patients: interaction with terbutaline.
European journal of clinical pharmacology 1988;33 Suppl():S25-32.
1986: Claes-Göran AH Löfdahl; B Järvholm; S Larsson
Tuberculosis in junior hospital doctors.
British journal of diseases of the chest 1986;80(1):96.
1986: Claes-Göran AH Löfdahl; Peter J Barnes
Calcium, calcium channel blockade and airways function.
Acta pharmacologica et toxicologica 1986;58 Suppl 2():91-111.
1985: Claes-Göran AH Löfdahl; Peter J Barnes
Calcium channel blockade and asthma--the current position.
European journal of respiratory diseases 1985;67(4):233-7.
1984: Claes-Göran AH Löfdahl; B Järvholm; L Zettergren; S Larsson
[Tuberculosis as an occupational disease among health care personnel].
Läkartidningen 1984;81(49):4659-62.
1984: I Sjögren; G Boman; Claes-Göran AH Löfdahl; B E Skoogh
[Tuberculosis treatment today].
Läkartidningen 1984;81(49):4655-9.
1984: Claes-Göran AH Löfdahl; N Svedmyr
Effects of xamoterol (ICI 118,587) in asthmatic patients.
British journal of clinical pharmacology 1984;18(4):597-601.
1984: Claes-Göran AH Löfdahl; N Svedmyr
A new beta 2-adrenoceptor agonist--D 2343--with long duration. Inhalation comparison with terbutaline in asthmatics.
Allergy 1984;39(6):485-9.
1984: E Berglund; Claes-Göran AH Löfdahl; N Svedmyr
Dosing of inhaled corticosteroids and therapeutic goals in asthmatic patients.
European journal of respiratory diseases 1984;65(5):319-20.
1984: Claes-Göran AH Löfdahl; K Svedmyr; N Svedmyr
Selectivity of bevantolol hydrochloride, a beta 1-adrenoceptor antagonist, in asthmatic patients.
Pharmacotherapy 1984;4(4):205-10.
1984: Claes-Göran AH Löfdahl; T Mellstrand; N Svedmyr
Glucocorticoids and asthma. Studies of resistance and systemic effects of glucocorticoids.
European journal of respiratory diseases. Supplement 1984;136():69-79.
1984: K Svedmyr; Claes-Göran AH Löfdahl; N Svedmyr
Nifedipine--a calcium channel blocker--in asthmatic patients. Interaction with terbutaline.
Allergy 1984;39(1):17-22.
1984: Claes-Göran AH Löfdahl; K Svedmyr; N Svedmyr; P Andersson; B Bengtsson; O A Olsson; B Waldeck
Comparison of beta 2-adrenoceptor stimulation in bronchial and skeletal muscle in experimental and clinical studies.
European journal of respiratory diseases. Supplement 1984;135():124-7.
1984: Claes-Göran AH Löfdahl; N Svedmyr
Selectivity of beta-adrenergic stimulating and blocking agents.
European journal of respiratory diseases. Supplement 1984;136():101-13.
1984: Claes-Göran AH Löfdahl; G E Marlin; N Svedmyr
Effects of beta 1-adrenoceptor stimulation and blockade studied in asthmatic airways.
European journal of respiratory diseases. Supplement 1984;135():151-2.
1983: Claes-Göran AH Löfdahl; G E Marlin; N Svedmyr
The effects of pafenolol and metoprolol on ventilatory function and haemodynamics during exercise by asthmatic patients.
European journal of clinical pharmacology 1983;24(3):289-95.
1983: Claes-Göran AH Löfdahl; G E Marlin; N Svedmyr
Pafenolol, a highly selective beta 1-adrenoceptor-antagonist, in asthmatic patients: interaction with terbutaline.
Clinical pharmacology and therapeutics 1983;33(1):1-9.
1982: Claes-Göran AH Löfdahl; N Svedmyr
Effect of prenalterol in asthmatic patients.
European journal of clinical pharmacology 1982;23(4):297-302.
1982: Claes-Göran AH Löfdahl; B Bengtsson; K Svedmyr; N Svedmyr
Two new beta 2-adrenoceptor agonists, D-2343 and QH 25, studied in asthmatic patients.
Allergy 1982;37(5):351-7.
1982: B Dahlström; T Mellstrand; Claes-Göran AH Löfdahl; M Johansson
Pharmacokinetic properties of noscapine.
European journal of clinical pharmacology 1982;22(6):535-9.
1982: N Svedmyr; Claes-Göran AH Löfdahl; K Svedmyr
The effect of powder aerosol compared to pressurized aerosol.
European journal of respiratory diseases. Supplement 1982;119():81-8.
1982: Claes-Göran AH Löfdahl
Selectivity of beta-adrenoceptor agonists and antagonists in asthmatics.
European journal of respiratory diseases. Supplement 1982;120():1-53.
1981: Claes-Göran AH Löfdahl; N Svedmyr
Cardioselectivity of atenolol and metoprolol. A study in asthmatic patients.
European journal of respiratory diseases 1981;62(6):396-404.
1980: Claes-Göran AH Löfdahl; E Odeblad
Biophysical variables relating to visco-elastic properties of mucus secretions, with special reference to NMR-methods for viscosity measurement.
European journal of respiratory diseases. Supplement 1980;110():113-27.
1979: B R Johansson; Claes-Göran AH Löfdahl
Ultrastructure of the microvessels in skeletal muscle in a case of systemic capillary leak syndrome.
Acta medica Scandinavica 1979;206(5):413-6.
1979: Claes-Göran AH Löfdahl; L Sölvell; A B Laurell; B R Johansson
Systemic capillary leak syndrome with monoclonal IgG and complement alterations. A case report on an episodic syndrome.
Acta medica Scandinavica 1979;206(5):405-12.